Navigation Links
CTi Wrist

ProductsCTi Wrist
Company Innovation Sports
Item CTi Wrist
Features 
  • Extension stop set specific to the patient's maximum range-of-motion
  • Easy-pull strap configuration makes application easy, quick and comfortable
  • Limited lifetime warranty on frame and hinge
  • Bi-axial, articulating hinge provides a controlled and anatomically-accurate movement of the wrist
  • 100% custom fit from an STS cast of the hand, wrist and forearm
  • Unique, open palm design is minimally invasive and limits obstructive of patient's grip
  • Thirteen standard color options
  • Custom paint available
  • Description The CTi Wrist is a custom wrist orthotic designed to limit the extension of the wrist specific to the patient's maximum range-of-motion.

    Indications:
  • Wrist reconstruction
  • Wrist sprains with TFCC tear-triangular fibrocartilage complex
  • Coles fracture - distal radius
  • Scaphoid nonunion
  • Partial tendon rupture
  • ORIF - Open reduction and internal fixation for fracture of carpal scaphoid
  • Ulnar styloid fracture
  • Compound Radius/ulna fracture
  • Villonod ulnar synovitis
  • Perilunate Dislocation
  • Transscaphoid Dislocation
  • To protect bone-ligament transfer
  • Radius fracture/extensor tendon rupture
  • Severely comminuted open distal radius and ulnar fracture
  • Info Innovation Sports
    Customer Service: (800) 222-4284
    Web site: http://www.isports.com/

    Related medicine products :

    1. Chan Wristrest
    2. WristJack®
    3. Hoffmann Classic Sterile Wrist Kit
    4. WristFixTM Distal Radius Fixation System
    5. Pennig Wrist Fixator
    6. Universal2 Total Wrist
    7. Biax™ Total Wrist System
    8. Avanta Total Wrist
    9. The Hub Cap Limited Wrist Fusion Plate
    10. The Spider Limited Wrist Fusion System
    11. Blue Line™ Wrist Control
    ELISA kit for Varicella-zoster IgG....
    The DSL-05-10-VZM Varicella Zoster IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Varicella Zoster Virus in human serum. This as...
    Inquire...
    ... Captia™ Mumps IgG Enzyme-linked Immunosorbent Assay (ELISA) ... determination of IgG antibody to Mumps virus ... be used for the determination of immune ... be used to demonstrate seroconversion or a ...
    Medicine Products:
    (Date:3/27/2017)... ... March 27, 2017 , ... ... weight management program at Women’s Excellence will help patients lose weight and keep ... exam. The specialists at Women's Excellence will measure BMI, body fat composition, ...
    (Date:3/27/2017)... ... March 27, 2017 , ... ... nurses and supply chain professionals, will hold their first Northeast Regional AHVAP Meeting. ... Bundles.” , “Increasingly, supply chain and value analysis professionals have a ‘seat ...
    (Date:3/27/2017)... ... March 27, 2017 , ... Sodium determination is ... complicated and require expert user knowledge. In a live webinar on April 11th ... simplified, yet highly accurate, determination of sodium. , It has long been known ...
    (Date:3/27/2017)... ... March 27, 2017 , ... ... with opioids alone responsible for over 33,000 of the 52,404 drug-related deaths in ... Bill (AB) 1512, which proposes a tax on prescription opioids to fund drug ...
    (Date:3/25/2017)... ... March 25, 2017 , ... Getting earned media coverage meaningful for ... , All through the year, Garden Media aims to provide material helpful to ... influencers and pitching client’s key messages to gain coveted media placements, Garden ...
    Breaking Medicine News(10 mins):
    (Date:3/27/2017)... and BOSTON , March 27, ... global pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: ... and commercialization of innovative therapies based upon tetracycline ... of sarecycline for the treatment of moderate to ... endpoints. Sarecycline is a once-daily, oral, narrow spectrum ...
    (Date:3/27/2017)... Calif. , March 27, 2017  Impax Laboratories, ... has appointed Paul M. Bisaro as Impax,s ... the Company,s Board, effective March 27, 2017. Mr. Bisaro ... served as Interim President and Chief Executive Officer since ... of generic and branded pharmaceutical experience, Mr. Bisaro, 56, ...
    (Date:3/27/2017)... -- PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company developing ... children, today reported financial results for the fourth ... and provided an update on its corporate activities. ... during the fourth quarter of 2016 through the ... study, and with our lead development candidate, PRX-OTC, ...
    Breaking Medicine Technology: